TRAX
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued
NASDAQ: TRAXV · HEALTHCARE · BIOTECHNOLOGY
$22.51
+0.00% today
Updated 2026-04-30
Market cap
$782.20M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$—
Dividend yield
—
52W range
$15 – $27
Volume
0.0M
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — |
| Cost of revenue | — | — |
| Gross profit | — | — |
| Gross margin | — | — |
| R&D | $97.59M | $152.34M |
| SG&A | $20.87M | $28.76M |
| Operating income | $-118.46M | $-181.10M |
| Operating margin | — | — |
| EBITDA | — | — |
| EBITDA margin | — | — |
| EBIT | — | — |
| Interest expense | — | — |
| Income tax | — | — |
| Effective tax rate | 0.0% | 0.0% |
| Net income | $-106.15M | $-163.71M |
| Net income growth (YoY) | — | -54.2% |
| Profit margin | — | — |